ImagineAR - CEO, Alen Paul Silverrstieen.
CEO, Alen Paul Silverrstieen.
Source: ImagineAR.
  • ImagineAR (IP) will facilitate augmented reality (AR) fan engagement for the Baltimore Ravens
  • The two-year revenue sharing agreement will see the team integrate ImagineAR’s AR platform with its mobile app to deliver immersive fan experiences
  • The partnership holds the potential for additional business with the NFL and other sports leagues
  • ImagineAR offers an AR platform that enables businesses to create and implement their own AR campaigns
  • ImagineAR (IP) is up by 50 per cent trading at $0.06 per share

ImagineAR (IP) will facilitate AR fan engagement for the Baltimore Ravens.

The two-year revenue sharing agreement will see the team integrate ImagineAR’s AR platform with its mobile app to deliver immersive metaverse experiences.

This marks the company’s first partnership with a top-tier professional sports team in the U.S.

“Our team strives to leverage advanced technology to deliver innovative and exceptional fan experiences,” stated Kevin Rochlitz, Chief Sales Officer of the Baltimore Ravens. “We are absolutely thrilled to be the first NFL team to integrate the award-winning ImagineAR technology into our digital communications’ mobile platform.”

“YinzCam, the Ravens app developer, is the leading global sports mobile app provider and we are expecting this fall launch will be a showcase of our AR sports fan platform to the NFL and other leagues,” added Alen Paul Silverrstieen, CEO of ImagineAR.

ImagineAR offers an AR platform that enables businesses to create and implement AR campaigns with no programming or technology experience.

ImagineAR (IP) is up by 50 per cent trading at $0.06 per share as of 11:51 am EST.


More From The Market Online
stock market down

@ the Bell: TSX hits near-month high

The TSX rose near highs not seen in a month, but a split between indices capped gains as mining and energy were the only…

FSD Pharma submits MS treatment clinical trial for review in Australia

FSD Pharma (CSE:HUGE) submits its MS treatment's Phase-1 Multiple Ascending Doses Clinical Trial Application for ethics review in Australia.

Cloud DX signs fourth contract with a provincial health authority

Cloud DX (TSXV:CDX) signs its fourth contract with a provincial health authority for remote patient monitoring.

International Petroleum stock rallies on Q1 results

Canadian energy stock International Petroleum Corp. (TSX:IPCO) rose in Tuesday trading on its Q1 2024 financial...